BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Erlotinib
1
Clinical efficacy and safety of erlotinib combined with chemotherapy in the treatment of advanced pancreatic cancer: A meta-analysis
3/22/2024 11:13:53 AM | Browse: 41 | Download: 69
2
Therapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
8/24/2021 2:07:00 AM | Browse: 302 | Download: 803
3
Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report
3/6/2019 8:51:28 AM | Browse: 693 | Download: 1078
4
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1079 | Download: 1441
5
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature
12/11/2014 2:06:00 PM | Browse: 872 | Download: 1075
6
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
9/15/2014 8:54:00 PM | Browse: 1127 | Download: 896
7
FDG-PET for predicting efficacy of EGFR-tyrosine kinase inhibitors in lung cancer
9/15/2014 4:56:00 PM | Browse: 1003 | Download: 1037
8
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1039 | Download: 1000
9
Distinct antifibrogenic effects of erlotinib, sunitinib and sorafenib on rat pancreatic stellate cells
8/26/2014 1:51:00 PM | Browse: 899 | Download: 755
10
Translational research in pancreatic ductal adenocarcinoma: current evidence and future concepts
8/20/2014 6:38:00 PM | Browse: 1220 | Download: 996
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345